Thuresson M - Search Results

1

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group*. Kosiborod M, et al. Among authors: thuresson m. Circulation. 2017 Jul 18;136(3):249-259. doi: 10.1161/CIRCULATIONAHA.117.029190. Epub 2017 May 18. Circulation. 2017. PMID: 28522450 Free PMC article. Clinical Trial.

2

Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study.

Schjesvold FH, Ludwig H, Mateos MV, Larocca A, Abdulhaq H, Norin S, Thuresson M, Bakker NA, Richardson PG, Sonneveld P. Schjesvold FH, et al. Among authors: thuresson m. Eur J Haematol. 2024 Mar;112(3):402-411. doi: 10.1111/ejh.14127. Epub 2023 Nov 15. Eur J Haematol. 2024. PMID: 37968873

3

Cardiovascular events in subgroups of patients during primary treatment of hypertension with candesartan or losartan.

Russell D, Stålhammar J, Bodegard J, Hasvold P, Thuresson M, Kjeldsen SE. Russell D, et al. Among authors: thuresson m. J Clin Hypertens (Greenwich). 2011 Mar;13(3):189-97. doi: 10.1111/j.1751-7176.2010.00410.x. Epub 2010 Dec 22. J Clin Hypertens (Greenwich). 2011. PMID: 21366850 Free PMC article.

4

Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.

Hedberg J, Sundström J, Thuresson M, Aarskog P, Oldgren J, Bodegard J. Hedberg J, et al. Among authors: thuresson m. J Intern Med. 2013 Oct;274(4):371-80. doi: 10.1111/joim.12103. Epub 2013 Jul 10. J Intern Med. 2013. PMID: 23800296 Free article.

5

Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study.

Carlborg A, Ferntoft L, Thuresson M, Bodegard J. Carlborg A, et al. Among authors: thuresson m. Bipolar Disord. 2015 Feb;17(1):76-85. doi: 10.1111/bdi.12234. Epub 2014 Jul 24. Bipolar Disord. 2015. PMID: 25056132

6

Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.

Hasvold LP, Bodegård J, Thuresson M, Stålhammar J, Hammar N, Sundström J, Russell D, Kjeldsen SE. Hasvold LP, et al. Among authors: thuresson m. J Hum Hypertens. 2014 Nov;28(11):663-9. doi: 10.1038/jhh.2014.43. Epub 2014 Jun 26. J Hum Hypertens. 2014. PMID: 25211055 Free PMC article.

7

Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients.

Carlborg A, Thuresson M, Ferntoft L, Bodegard J. Carlborg A, et al. Among authors: thuresson m. Ther Adv Psychopharmacol. 2015 Feb;5(1):13-21. doi: 10.1177/2045125314560740. Ther Adv Psychopharmacol. 2015. PMID: 25653826 Free PMC article.

8

Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting.

Hasvold P, Thuresson M, Sundström J, Hammar N, Kjeldsen SE, Johansson G, Holme I, Bodegård J. Hasvold P, et al. Among authors: thuresson m. Clin Drug Investig. 2016 Mar;36(3):225-33. doi: 10.1007/s40261-015-0372-9. Clin Drug Investig. 2016. PMID: 26718960 Free PMC article.

9

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013.

Norhammar A, Bodegård J, Nyström T, Thuresson M, Eriksson JW, Nathanson D. Norhammar A, et al. Among authors: thuresson m. Diabetologia. 2016 Aug;59(8):1692-701. doi: 10.1007/s00125-016-3971-y. Epub 2016 May 18. Diabetologia. 2016. PMID: 27189067

10

Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality.

Eriksson JW, Bodegard J, Nathanson D, Thuresson M, Nyström T, Norhammar A. Eriksson JW, et al. Among authors: thuresson m. Diabetes Res Clin Pract. 2016 Jul;117:39-47. doi: 10.1016/j.diabres.2016.04.055. Epub 2016 May 6. Diabetes Res Clin Pract. 2016. PMID: 27329021 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page